MLchartDataset catalogue

Bcr-abl peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-011926

A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response.

Table 1. Record
IdentifierMLC-T-ONC-011926
FieldOncology and biomedicine
Synonymsbcr-abl vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-011926",
  "term": "Bcr-abl peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response.",
  "synonyms": [
    "bcr-abl vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bcr-abl-peptide-vaccine/"
}

Record 3,373 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.